quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:22·149d
SECFiling
Pulmonx Corporation logo

SEC Form EFFECT filed by Pulmonx Corporation

LUNG· Pulmonx Corporation
Health Care
Original source

Companies

  • LUNG
    Pulmonx Corporation
    Health Care

Recent analyst ratings

  • Jul 31UpdatePiper Sandler$2.50
  • Mar 10UpdateD. Boral Capital$17.00
  • Dec 11UpdateCitigroup$7.50
  • Jun 4UpdateLake Street$12.00
  • Feb 23UpdateWells Fargo$14.00
  • Sep 5UpdateCraig Hallum$18.00

Related

  • SEC1d
    SEC Form DEFA14A filed by Pulmonx Corporation
  • SEC1d
    SEC Form DEF 14A filed by Pulmonx Corporation
  • PR8d
    Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Pulmonx Corporation
  • SEC44d
    SEC Form S-8 filed by Pulmonx Corporation
  • SEC44d
    SEC Form 10-K filed by Pulmonx Corporation
  • INSIDER50d
    Chief Science &Techn. Officer Radhakrishnan Srikanth sold $14,991 worth of shares (10,483 units at $1.43) and was granted 175,000 shares, increasing direct ownership by 91% to 345,736 units (SEC Form 4)
  • INSIDER50d
    President and CEO French Glendon E. Iii sold $96,973 worth of shares (67,813 units at $1.43), decreasing direct ownership by 5% to 1,409,511 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022